期刊文献+

醋酸氟卡尼合成路线改进 被引量:1

Process improvement on synthesis of flecainide acetate
下载PDF
导出
摘要 以商品化2,5-二(2,2,2-三氟乙氧基)苯甲酸(Ⅰ)为原料,二氯亚砜为酰氯化试剂,得到2,5-二(2,2,2-三氟乙氧基)苯甲酰氯(Ⅱ),中间体Ⅱ再与2-氨甲基哌啶反应得到盐酸氟卡尼(Ⅲ),化合物Ⅲ通过碱中和再与醋酸络合成盐得到目标产物醋酸氟卡尼。考察了投料比、反应时间以及溶剂对化合物Ⅲ收率的影响,优选的反应条件为:n(Ⅰ)∶n(2-氨甲基哌啶)=1∶1.8(其中,化合物Ⅰ先活化成酰氯),以四氢呋喃为溶剂,冰浴搅拌2.0 h,得到盐酸氟卡尼。再以乙醇为溶剂,Na OH为碱,回流中和0.5 h,得到氟卡尼(Ⅳ);最后,选用异丙醇为溶剂,中间体Ⅳ与醋酸回流0.5h,冷却析出得到目标产物。4步反应总收率为39.2%,经过两次结晶,最终产物醋酸氟卡尼HPLC纯度高于99.7%。 2,5-Bis(2,2,2-trifluoroethoxy)benzoyl chloride(Ⅱ)was synthesized by acylating chlorination between commercial 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid(Ⅰ)and dichlorosulfoxide.The amination of intermediateⅡand piperidin-2-ylmethanamine led to flecainide hydrochloride(Ⅲ).Targeting compound flecainide acetate was obtained by neutralization of compoundⅢwith alkali and then salification with acetic acid.The effects of molar ratio of raw materials,reaction time and solvent on the yield of compoundⅢwere investigated.The optimized reaction conditions for synthesis of compoundⅢwere as follows:n(Ⅰ)∶n(piperidin-2-ylmethanamine)=1∶1.8(herein,compoundⅠwas first activated to form intermediateⅡ),using tetrahydrofuran as solvent,and reaction for 2.0 h in an ice bath.Subsequently,flecainide(Ⅳ)was prepared by neutralization of compoundⅢwith NaOH using ethanol as solvent and refluxing for 0.5 h.Finally,intermediateⅣwas reflux in the presence of acetic acid for 0.5 h using isopropyl alcohol as solvent and then cooled,and the target product was obtained.The total yield of four-step reaction was 39.2%,and the purity of the final product was higher than 99.7%by HPLC analysis after two crystallization.
作者 刘潇 刘霞 李咏乐 杨超 胡昱 袁忠义 LIU Xiao;LIU Xia;LI Yongle;YANG Chao;HU Yu;YUAN Zhongyi(College of Chemistry,Nanchang University,Nanchang 330031,Jiangxi,China)
出处 《精细化工》 EI CAS CSCD 北大核心 2021年第11期2336-2340,共5页 Fine Chemicals
基金 国家自然科学基金(21861025)。
关键词 2 5-二(2 2 2-三氟乙氧基)苯甲酸 醋酸氟卡尼 结晶 工艺改进 医药原料 2 5-bis(2 2 2-trifluoroethoxy)benzoic acid flecainide acetate crystallization process improvement drug materials
  • 相关文献

参考文献4

二级参考文献27

  • 1.中国药典二部[S].,2000年版.附录77.
  • 2周海钧主译.药品注册的国际技术要求·质量部分·[M].北京:人民卫生出版社,2000.82.
  • 3USP[S].27-NF22.Asian Edition,2004:2224.
  • 4BP [S]. 2002 : A200.
  • 5EP [S]. 3rd Edition Supplement, 2000:32.
  • 6JP [S] . 14, 2001: 85.
  • 7Paulus Kirchhof,Dietrich Andresen,Ralph Bosch,Martin Borggrefe,Thomas Meinertz,Ulli Parade,Ursula Ravens,Alexander Samol,Gerhard Steinbeck,Andras Treszl,Karl Wegscheider,Günter Breithardt.Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial[J]. The Lancet . 2012 (9838)
  • 8Ibrahim Marai,Asaad Khoury,Mahmoud Suleiman,Lior Gepstein,Miri Blich,Abraham Lorber,Monther Boulos.Importance of Ventricular Tachycardia Storms Not Terminated by Implantable Cardioverter Defibrillators Shocks in Patients With CASQ2 Associated Catecholaminergic Polymorphic Ventricular Tachycardia[J]. The American Journal of Cardiology . 2012 (1)
  • 9Nian Liu,Marco Denegri,Yanfei Ruan,José Everardo Avelino-Cruz,Andrea Perissi,Sara Negri,Carlo Napolitano,William A. Coetzee,Penelope A. Boyden,Silvia G. Priori.Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity[J]. Circulation Research . 2011 (3)
  • 10Eleonora Savio Galimberti,Bj?rn C. Knollmann.Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca 2+ waves in permeabilized myocytes lacking calsequestrin[J]. Journal of Molecular and Cellular Cardiology . 2011 (5)

共引文献37

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部